Latest Breaking News On - Laboratory animal center - Page 1 : comparemela.com

New Drug Successfully Treats Fatty Liver Disease in Primate Model

Millions of people are affected by nonalcoholic steatohepatitis (NASH), which is a serious liver disease. A newly discovered amino acid compound has been found to successfully treat nonalcoholic fatty liver disease in non-human primates, representing a significant step towards the development of th

United statesYang zhaoZuowen zhengJinpeng zhaoEugene chenShuangshuang chenWenbin caoChengshuang chuBo wenLinying jiaXiaojing gaoAlexandrac finneyY eugene chenZhipeng liuXuelian xiongJifeng zhang

Potential drug treats fatty liver disease in animal models, brings hope for first human treatment: Nonalcoholic steatohepatitis, or NASH, is a severe liver disease and impacts millions of people

Potential drug treats fatty liver disease in animal models, brings hope for first human treatment: Nonalcoholic steatohepatitis, or NASH, is a severe liver disease and impacts millions of people
sciencedaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sciencedaily.com Daily Mail and Mail on Sunday newspapers.

United statesJifeng zhangEugene chenMichigan medicineLaboratory animal centerXi an jiaotong university health science centerCardiovascular sciencesPeking university health science centerHuetwell professorCardiovascular medicineMichigan medical

Tripeptide Treats Fatty Liver Disease in Non-Human Primates

Researchers say studies describe a highly translatable NASH model and highlight the need for clinical evaluation of DT-109.

United statesJifeng zhangEugene chenUniversity of michiganMichigan medicineHuetwell professorCardiovascular medicineMichigan medicalCell metabolismLaboratory animal centerXi an jiaotong university health science centerCardiovascular sciencesPeking university health scienceDiapin therapeutics

Drug Candidate for Fatty Liver Disease Shows Promise in Animal Models

A recently developed amino acid compound successfully treats nonalcoholic fatty liver disease in non-human primates, bringing scientists one step closer to the first human treatment for the condition.

United statesJifeng zhangEugene chenTechnology networkMichigan medicineLaboratory animal centerXi an jiaotong university health science centerCardiovascular sciencesPeking university health science centerHuetwell professorCardiovascular medicineMichigan medical

Potential drug DT-109 brings hope for human fatty liver treatment

Washington, Apr 11 (Prensa Latina) A recently developed amino acid compound successfully treats nonalcoholic fatty liver disease in non-human primates bringing scientists one step closer to the first human treatment for the condition that is rapidly increasing around the world, a study suggests.

United statesJifeng zhangEugene chenMichigan medicineLaboratory animal centerXi an jiaotong university health science centerCardiovascular sciencesPeking university health science centerHuetwell professorCardiovascular medicineMichigan medical